Skip to main content

Table 2 Baseline characteristics stratified by mortality and survival of patients with a certified outcome in Mashhad City from Feb 14, to May 11, 2020

From: Epidemiological characteristics and initial spatiotemporal visualisation of COVID-19 in a major city in the Middle East

Reference All patients Non-survivors Survivors p-value
Number of patients (%) 2943 (100) 707 (24) 2236 (76)  
Median age of the patients 57.0 68.0 52.0 0.0001*
Age range 40.0–71.0 59.0–79.0 36.0–66.0
Days from onset to hospital admission 2.0 2.0 2.0 0.0695
Range of days 1.0–4.0 0.0–4.0 1.0–4.0
Days from hospital admission to outcome 5.0 6.0 4.0 < 0.0001*
Range of days 2.0–8.0 2.0–10.0 2.0–7.0
Demographics & Clinical Characteristics Number (%) Number (%) Number (%)  
Sex 0.5832
 Female 1179 (40.06) 277 (39.18) 902 (40.34)
 Male 1764 (59.94) 430 (60.82) 1334 (59.66)
Co-morbidity
 Diabetes 405 (13.76) 129 (18.25) 276 (12.34) 0.0001*
 CVD 614 (20.86) 197 (27.86) 417 (18.64) < 0.0001*
 Liver disorders 89 (3.02) 28 (3.96) 61 (2.72) 0.0953
 CRD 120 (4.07) 38 (5.37) 82 (3.67) 0.0453*
 Nervous diseases 69 (2.34) 28 (3.96) 41(1.83) 0.0011*
 COPD 181 (6.15) 71 (10.04) 110 (4.91) < 0.0001*
 Malignancy (any) 73 (2.48) 39 (5.51) 34 (1.52) < 0.0001*
Initial symptoms
 Fever 1720 (58.44) 385 (54.45) 1335 (59.70) 0.0135*
 Cough 1874 (63.67) 378 (53.46) 1496 (66.90) < 0.0001*
 Dyspnoea 2111 (71.72) 579 (81.90) 1532 (68.51) < 0.0001*
 Weakness 533 (18.11) 122 (17.25) 411 (18.38) 0.4984
 Myalgia 429 (14.57) 71 (10.04) 358 (16.01) < 0.0001*
 Dizziness 247 (8.39) 80 (11.31) 167 (7.47) 0.0013*
 Sore throat 352 (11.96) 47 (6.64) 305 (13.64) < 0.0001*
 Sputum 55 (1.86) 5 (0.70) 50 (2.23) 0.0088*
 Diarrhoea 101 (3.43) 16 (2.26) 85 (3.80) 0.0501
 Nausea or vomiting 246 (8.36) 39 (5.51) 207 (9.26) 0.0017*
 Headache 245 (8.32) 35 (4.95) 210 (9.39) 0.0001*
 Chest pain 223 (7.57) 49 (6.93) 174 (7.78) 0.2906
 Abdominal pain 39 (1.32) 3 (0.42) 36 (1.61) 0.0162*
 Arthralgia 176 (5.98) 25 (3.53) 151 (6.75) 0.0016*
 Pharyngitis 37 (1.25) 6 (0.85) 31 (0.14) 0.2633
 Conjunctivitis 18 (0.61) 2 (0.28) 15 (0.72) 0.1984
 Seizure 22 (0.75) 6 (0.85) 16 (0.71) 0.7203
Abnormal chest X-ray 697 (23.68) 186 (26.30) 511 (22.85) 0.0596
 End-points
 ICU admission 338 (11.48) 150 (21.21) 188 (8.40) < 0.0001*
 Ventilator 549 (18.65) 209 (29.56) 340 (15.20) < 0.0001*
 Coma 19 (0.65) 9 (1.27) 10 (0.45) 0.0168*
Disease severity status 0.0033*
 General 2418 (82.16) 551 (77.93) 1867 (83.50)
 Severe 503 (17.09) 150 (21.22) 353 (15.78)
 Critical 22 (0.75) 6 (0.85) 16 (0.72)
  1. CVD Cardiovascular Diseases, CRD Chronic Renal Diseases, COPD Chronic Obstructive Pulmonary Diseases, ICU Intensive Care Unit. *Significant values